STEVENSON, Md., Sept. 25, 2017 -- The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of Texas on behalf of purchasers of TechnipFMC plc (NYSE:FTI) (“TechnipFMC” or the “Company”) securities during the period between April 27, 2017 and July 24, 2017, inclusive (the “Class Period”). Investors who wish to become proactively involved in the litigation have until October 2, 2017 to seek appointment as lead plaintiff.
If you wish to choose counsel to represent you and the class, you must apply to be appointed lead plaintiff and be selected by the Court. The lead plaintiff will direct the litigation and participate in important decisions including whether to accept a settlement for the class in the action. The lead plaintiff will be selected from among applicants claiming the largest loss from investment in TechnipFMC securities during the Class Period. Members of the class will be represented by the lead plaintiff and counsel chosen by the lead plaintiff. No class has yet been certified in the above action.
The complaint accuses the defendants of violations of the Securities Exchange Act of 1934 by virtue of the defendants’ failure to disclose during the Class Period that the Company had a material weakness in its internal control over rates used in the calculations of the foreign currency effects on certain of its engineering and construction projects.
According to the complaint, following a July 24, 2017 press release disclosing that errors existed within certain rates used in the calculations of the foreign currency effects, the value of TechnipFMC shares declined significantly.
If you have suffered a loss in excess of $100,000 from investment in TechnipFMC securities purchased on or after April 27, 2017 and held through the revelation of negative information during and/or at the end of the Class Period and would like to learn more about this lawsuit and your ability to participate as a lead plaintiff, without cost or obligation to you, please visit our website at http://www.browerpiven.com/currentsecuritiescases.html. You may also request more information by contacting Brower Piven either by email at [email protected] or by telephone at (410) 415-6616.
Attorneys at Brower Piven have extensive experience in litigating securities and other class action cases and have been advocating for the rights of shareholders since the 1980s. If you choose to retain counsel, you may retain Brower Piven without financial obligation or cost to you, or you may retain other counsel of your choice. You need take no action at this time to be a member of the class.
CONTACT: Charles J. Piven
Brower Piven, A Professional Corporation
1925 Old Valley Road
Stevenson, Maryland 21153
Telephone: 410-415-6616
[email protected]


California DMV Proposes New Safety Rules for Autonomous Vehicles After Waymo Incidents
Hyundai Recalls Over 51,000 Vehicles in the U.S. Due to Fire Risk From Trailer Wiring Issue
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
Nvidia and Groq Strike Strategic AI Inference Licensing Deal
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
Hanwha Signals Readiness to Build Nuclear-Powered Submarines at Philly Shipyard for U.S. Navy
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
Warner Bros. Discovery Shares Slide Amid Report of Potential Paramount Skydance Lawsuit
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge
Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
TSMC Honors Japanese Chip Equipment Makers With 2025 Supplier Awards
BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands
FDA Approves Mitapivat for Anemia in Thalassemia Patients
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training 



